Highview Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Highview Capital Management's AMGN Position: Q2 2026 in Review
Highview Capital Management increased its Amgen (AMGN) stake by 2.7% in Q2 2026, buying an estimated $35.3K and bringing the position to 3,963 shares worth $1.44M. The position accounts for 0.41% of the portfolio, ranked #65.
Highview Capital Management first reported a position in AMGN in Q4 2021 and has held it in 8 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Highview Capital Management held 3,963 shares of Amgen worth $1.44M as of Q2 2026.
- Highview Capital Management bought 103 Amgen shares in Q2 2026, an estimated $35.3K.
- Amgen made up 0.41% of Highview Capital Management's portfolio in Q2 2026, its #65 holding.
- Highview Capital Management first reported a position in Amgen in Q4 2021 and has held it in 8 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Highview Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.